Aspira Women's Health (AWHL) director ups stake with 55K share buy at $0.45

Rhea-AI Filing Summary

Aspira Women's Health director Jeffrey K. Cohen reported open-market purchases of common stock and warrants in an amended Form 4. On September 17, 2025, he bought 55,556 shares of common stock at $0.45 per share, bringing his directly held common stock position to 374,906 shares.

He also purchased a warrant covering 41,667 shares of common stock with an exercise price of $0.75 per share, expiring on September 17, 2030, and now holds 41,667 of these warrants directly. Separately, 71,010 shares of common stock are reported as held indirectly through his spouse.

The filing further shows a direct warrant position with an exercise price of $0.35 per share, expiring on March 5, 2031, relating to 450,318 underlying shares of common stock. According to the footnote, this amendment corrects prior disclosures about the number and nature of shares and warrants held on September 17, 2025.

Insider Trade Summary

Net Buyer: 55,556 shares

Net Buy 4 txns

Insider cohen Jeffrey k

Role Director

Bought 97,223 shs ($25K)

Type	Security	Shares	Price	Value
Purchase	Warrant (Right to Buy)	41,667	$0.00	$0.00
Purchase	Common Stock	55,556	$0.45	$25K
holding	Warrant (Right to Buy)	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Warrant (Right to Buy) — 491,985 shares (Direct); Common Stock — 374,906 shares (Direct); Common Stock — 71,010 shares (Indirect, By Spouse)

Footnotes (1)

1. F1. This report is being filed to correct the number and nature of shares held by Dr. Cohen on September 17, 2025, the number of shares held by Dr. Cohen's spouse on September 17, 2025 and the presentation of the warrants held on September 17, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 05/29/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

cohen Jeffrey k

(Last) (First) (Middle)

C/O ASPIRA WOMEN'S HEALTH INC

12117 BEE CAVES RD, BLDG 3-100

(Street)

AUSTIN TEXAS 78738

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aspira Women's Health Inc. [ AWHL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
09/19/2025

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2025		P		55,556	A	$0.45	374,906(1)	D
Common Stock								71,010(1)	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant (Right to Buy)	$0.75	09/17/2025		P		41,667		09/17/2025	09/17/2030	Common Stock, par value $0.001	41,667	$0	41,667(1)	D
Warrant (Right to Buy)	$0.35							09/12/2025	03/05/2031	Common Stock, par value $0.001	450,318		450,318	D

Explanation of Responses:

1. This report is being filed to correct the number and nature of shares held by Dr. Cohen on September 17, 2025, the number of shares held by Dr. Cohen's spouse on September 17, 2025 and the presentation of the warrants held on September 17, 2025.

	/s/ Jeffrey Cohen	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)